Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Intraosseous Infusion Needle Set Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Intraosseous Infusion Needle Set Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 118 Pages
Report ld: 5344841
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Intraosseous Infusion Needle Set Market Size(US$)
CAGR 2025-2031
3.1%
Market Size,2031
USD 85
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 70.8 million
Market Forecast in 2031(Value)
US$ 85 million
CAGR
3.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Intraosseous Infusion Needle Set market is projected to grow from US$ 68.9 million in 2024 to US$ 85 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Intraosseous Infusion Needle Set is intended for use as an alternative to intravenous access during emergencies, permitting infusion of drugs and fluids.
The intraosseous infusion needle set is a medical device used for infusion or drug injection in the bone marrow cavity in emergency situations. In emergency situations, such as severe trauma, cardiac arrest, or shock, intravenous access may be difficult or impossible to obtain. At this time, the intraosseous infusion needle set can be used as an alternative to quickly deliver fluid or medicine to the bone marrow cavity to maintain the life support and stability of the patient.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Intraosseous Infusion Needle Set market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Cook Medical
- BD
- Teleflex
- Medax
- BPB MEDICA
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Child Type
- Adult Type
Segment by Application
- Hospitals
- Ambulatory Surgical Centres
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Intraosseous Infusion Needle Set study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Intraosseous Infusion Needle Set: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Intraosseous Infusion Needle Set Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Child Type
1.2.3 Adult Type
1.3 Market Segmentation by Application
1.3.1 Global Intraosseous Infusion Needle Set Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centres
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intraosseous Infusion Needle Set Revenue Estimates and Forecasts 2020-2031
2.2 Global Intraosseous Infusion Needle Set Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Intraosseous Infusion Needle Set Sales Estimates and Forecasts 2020-2031
2.4 Global Intraosseous Infusion Needle Set Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Intraosseous Infusion Needle Set Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Intraosseous Infusion Needle Set Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Child Type Market Size by Manufacturers
3.5.2 Adult Type Market Size by Manufacturers
3.6 Global Intraosseous Infusion Needle Set Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Intraosseous Infusion Needle Set Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Intraosseous Infusion Needle Set Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Intraosseous Infusion Needle Set Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Intraosseous Infusion Needle Set Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Intraosseous Infusion Needle Set Sales and Revenue by Type (2020-2031)
6.4 North America Intraosseous Infusion Needle Set Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Intraosseous Infusion Needle Set Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Intraosseous Infusion Needle Set Sales and Revenue by Type (2020-2031)
7.4 Europe Intraosseous Infusion Needle Set Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Intraosseous Infusion Needle Set Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Intraosseous Infusion Needle Set Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Intraosseous Infusion Needle Set Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Intraosseous Infusion Needle Set Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Intraosseous Infusion Needle Set Sales and Revenue by Type (2020-2031)
9.4 Central and South America Intraosseous Infusion Needle Set Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Intraosseous Infusion Needle Set Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Intraosseous Infusion Needle Set Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Intraosseous Infusion Needle Set Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Intraosseous Infusion Needle Set Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Cook Medical
11.1.1 Cook Medical Corporation Information
11.1.2 Cook Medical Business Overview
11.1.3 Cook Medical Intraosseous Infusion Needle Set Product Models, Descriptions and Specifications
11.1.4 Cook Medical Intraosseous Infusion Needle Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Cook Medical Intraosseous Infusion Needle Set Sales by Product in 2024
11.1.6 Cook Medical Intraosseous Infusion Needle Set Sales by Application in 2024
11.1.7 Cook Medical Intraosseous Infusion Needle Set Sales by Geographic Area in 2024
11.1.8 Cook Medical Intraosseous Infusion Needle Set SWOT Analysis
11.1.9 Cook Medical Recent Developments
11.2 BD
11.2.1 BD Corporation Information
11.2.2 BD Business Overview
11.2.3 BD Intraosseous Infusion Needle Set Product Models, Descriptions and Specifications
11.2.4 BD Intraosseous Infusion Needle Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 BD Intraosseous Infusion Needle Set Sales by Product in 2024
11.2.6 BD Intraosseous Infusion Needle Set Sales by Application in 2024
11.2.7 BD Intraosseous Infusion Needle Set Sales by Geographic Area in 2024
11.2.8 BD Intraosseous Infusion Needle Set SWOT Analysis
11.2.9 BD Recent Developments
11.3 Teleflex
11.3.1 Teleflex Corporation Information
11.3.2 Teleflex Business Overview
11.3.3 Teleflex Intraosseous Infusion Needle Set Product Models, Descriptions and Specifications
11.3.4 Teleflex Intraosseous Infusion Needle Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Teleflex Intraosseous Infusion Needle Set Sales by Product in 2024
11.3.6 Teleflex Intraosseous Infusion Needle Set Sales by Application in 2024
11.3.7 Teleflex Intraosseous Infusion Needle Set Sales by Geographic Area in 2024
11.3.8 Teleflex Intraosseous Infusion Needle Set SWOT Analysis
11.3.9 Teleflex Recent Developments
11.4 Medax
11.4.1 Medax Corporation Information
11.4.2 Medax Business Overview
11.4.3 Medax Intraosseous Infusion Needle Set Product Models, Descriptions and Specifications
11.4.4 Medax Intraosseous Infusion Needle Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Medax Intraosseous Infusion Needle Set Sales by Product in 2024
11.4.6 Medax Intraosseous Infusion Needle Set Sales by Application in 2024
11.4.7 Medax Intraosseous Infusion Needle Set Sales by Geographic Area in 2024
11.4.8 Medax Intraosseous Infusion Needle Set SWOT Analysis
11.4.9 Medax Recent Developments
11.5 BPB MEDICA
11.5.1 BPB MEDICA Corporation Information
11.5.2 BPB MEDICA Business Overview
11.5.3 BPB MEDICA Intraosseous Infusion Needle Set Product Models, Descriptions and Specifications
11.5.4 BPB MEDICA Intraosseous Infusion Needle Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BPB MEDICA Intraosseous Infusion Needle Set Sales by Product in 2024
11.5.6 BPB MEDICA Intraosseous Infusion Needle Set Sales by Application in 2024
11.5.7 BPB MEDICA Intraosseous Infusion Needle Set Sales by Geographic Area in 2024
11.5.8 BPB MEDICA Intraosseous Infusion Needle Set SWOT Analysis
11.5.9 BPB MEDICA Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Intraosseous Infusion Needle Set Industry Chain
12.2 Intraosseous Infusion Needle Set Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Intraosseous Infusion Needle Set Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Intraosseous Infusion Needle Set Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Intraosseous Infusion Needle Set Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Intraosseous Infusion Needle Set Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Intraosseous Infusion Needle Set Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Intraosseous Infusion Needle Set Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Intraosseous Infusion Needle Set Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Intraosseous Infusion Needle Set Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Intraosseous Infusion Needle Set Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Intraosseous Infusion Needle Set Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Intraosseous Infusion Needle Set Sales by Region (2020-2025) & (K Units)
Table 8. Global Intraosseous Infusion Needle Set Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Intraosseous Infusion Needle Set Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Intraosseous Infusion Needle Set Sales Share by Manufacturers (2020-2025)
Table 12. Global Intraosseous Infusion Needle Set Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Intraosseous Infusion Needle Set Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Intraosseous Infusion Needle Set by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intraosseous Infusion Needle Set as of 2024)
Table 16. Global Intraosseous Infusion Needle Set Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Intraosseous Infusion Needle Set Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Intraosseous Infusion Needle Set Manufacturing Base and Headquarters
Table 19. Global Intraosseous Infusion Needle Set Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Intraosseous Infusion Needle Set Sales by Type (2020-2025) & (K Units)
Table 23. Global Intraosseous Infusion Needle Set Sales by Type (2026-2031) & (K Units)
Table 24. Global Intraosseous Infusion Needle Set Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Intraosseous Infusion Needle Set Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Intraosseous Infusion Needle Set ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Intraosseous Infusion Needle Set Sales by Application (2020-2025) & (K Units)
Table 29. Global Intraosseous Infusion Needle Set Sales by Application (2026-2031) & (K Units)
Table 30. Intraosseous Infusion Needle Set High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Intraosseous Infusion Needle Set Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Intraosseous Infusion Needle Set Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Intraosseous Infusion Needle Set ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Intraosseous Infusion Needle Set Growth Accelerators and Market Barriers
Table 37. North America Intraosseous Infusion Needle Set Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Intraosseous Infusion Needle Set Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Intraosseous Infusion Needle Set Growth Accelerators and Market Barriers
Table 40. Europe Intraosseous Infusion Needle Set Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Intraosseous Infusion Needle Set Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Intraosseous Infusion Needle Set Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Intraosseous Infusion Needle Set Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Intraosseous Infusion Needle Set Growth Accelerators and Market Barriers
Table 45. Southeast Asia Intraosseous Infusion Needle Set Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Intraosseous Infusion Needle Set Investment Opportunities and Key Challenges
Table 47. Central and South America Intraosseous Infusion Needle Set Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Intraosseous Infusion Needle Set Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Intraosseous Infusion Needle Set Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Cook Medical Corporation Information
Table 51. Cook Medical Description and Major Businesses
Table 52. Cook Medical Product Models, Descriptions and Specifications
Table 53. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Cook Medical Sales Value Proportion by Product in 2024
Table 55. Cook Medical Sales Value Proportion by Application in 2024
Table 56. Cook Medical Sales Value Proportion by Geographic Area in 2024
Table 57. Cook Medical Intraosseous Infusion Needle Set SWOT Analysis
Table 58. Cook Medical Recent Developments
Table 59. BD Corporation Information
Table 60. BD Description and Major Businesses
Table 61. BD Product Models, Descriptions and Specifications
Table 62. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. BD Sales Value Proportion by Product in 2024
Table 64. BD Sales Value Proportion by Application in 2024
Table 65. BD Sales Value Proportion by Geographic Area in 2024
Table 66. BD Intraosseous Infusion Needle Set SWOT Analysis
Table 67. BD Recent Developments
Table 68. Teleflex Corporation Information
Table 69. Teleflex Description and Major Businesses
Table 70. Teleflex Product Models, Descriptions and Specifications
Table 71. Teleflex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Teleflex Sales Value Proportion by Product in 2024
Table 73. Teleflex Sales Value Proportion by Application in 2024
Table 74. Teleflex Sales Value Proportion by Geographic Area in 2024
Table 75. Teleflex Intraosseous Infusion Needle Set SWOT Analysis
Table 76. Teleflex Recent Developments
Table 77. Medax Corporation Information
Table 78. Medax Description and Major Businesses
Table 79. Medax Product Models, Descriptions and Specifications
Table 80. Medax Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Medax Sales Value Proportion by Product in 2024
Table 82. Medax Sales Value Proportion by Application in 2024
Table 83. Medax Sales Value Proportion by Geographic Area in 2024
Table 84. Medax Intraosseous Infusion Needle Set SWOT Analysis
Table 85. Medax Recent Developments
Table 86. BPB MEDICA Corporation Information
Table 87. BPB MEDICA Description and Major Businesses
Table 88. BPB MEDICA Product Models, Descriptions and Specifications
Table 89. BPB MEDICA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BPB MEDICA Sales Value Proportion by Product in 2024
Table 91. BPB MEDICA Sales Value Proportion by Application in 2024
Table 92. BPB MEDICA Sales Value Proportion by Geographic Area in 2024
Table 93. BPB MEDICA Intraosseous Infusion Needle Set SWOT Analysis
Table 94. BPB MEDICA Recent Developments
Table 95. Key Raw Materials Distribution
Table 96. Raw Materials Key Suppliers
Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 98. Milestones in Production Technology Evolution
Table 99. Distributors List
Table 100. Market Trends and Market Evolution
Table 101. Market Drivers and Opportunities
Table 102. Market Challenges, Risks, and Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Intraosseous Infusion Needle Set Product Picture
Figure 2. Global Intraosseous Infusion Needle Set Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Child Type Product Picture
Figure 4. Adult Type Product Picture
Figure 5. Global Intraosseous Infusion Needle Set Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospitals
Figure 7. Ambulatory Surgical Centres
Figure 8. Others
Figure 9. Intraosseous Infusion Needle Set Report Years Considered
Figure 10. Global Intraosseous Infusion Needle Set Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 12. Global Intraosseous Infusion Needle Set Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Intraosseous Infusion Needle Set Revenue Market Share by Region (2020-2031)
Figure 14. Global Intraosseous Infusion Needle Set Sales (2020-2031) & (K Units)
Figure 15. Global Intraosseous Infusion Needle Set Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Intraosseous Infusion Needle Set Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Intraosseous Infusion Needle Set Sales Volume Market Share in 2024
Figure 18. Global Intraosseous Infusion Needle Set Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Child Type Revenue Market Share by Manufacturer in 2024
Figure 21. Adult Type Revenue Market Share by Manufacturer in 2024
Figure 22. Global Intraosseous Infusion Needle Set Sales Market Share by Type (2020-2031)
Figure 23. Global Intraosseous Infusion Needle Set Revenue Market Share by Type (2020-2031)
Figure 24. Global Intraosseous Infusion Needle Set Sales Market Share by Application (2020-2031)
Figure 25. Global Intraosseous Infusion Needle Set Revenue Market Share by Application (2020-2031)
Figure 26. North America Intraosseous Infusion Needle Set Sales YoY (2020-2031) & (K Units)
Figure 27. North America Intraosseous Infusion Needle Set Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Intraosseous Infusion Needle Set Sales Revenue (US$ Million) in 2024
Figure 29. North America Intraosseous Infusion Needle Set Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Intraosseous Infusion Needle Set Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Intraosseous Infusion Needle Set Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Intraosseous Infusion Needle Set Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Intraosseous Infusion Needle Set Sales Revenue (US$ Million) in 2024
Figure 39. Europe Intraosseous Infusion Needle Set Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Intraosseous Infusion Needle Set Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 44. France Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Intraosseous Infusion Needle Set Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Intraosseous Infusion Needle Set Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Intraosseous Infusion Needle Set Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Intraosseous Infusion Needle Set Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Intraosseous Infusion Needle Set Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 59. India Intraosseous Infusion Needle Set Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Intraosseous Infusion Needle Set Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Intraosseous Infusion Needle Set Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Intraosseous Infusion Needle Set Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Intraosseous Infusion Needle Set Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Intraosseous Infusion Needle Set Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Intraosseous Infusion Needle Set Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Intraosseous Infusion Needle Set Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Intraosseous Infusion Needle Set Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Intraosseous Infusion Needle Set Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Intraosseous Infusion Needle Set Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Intraosseous Infusion Needle Set Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Intraosseous Infusion Needle Set Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Intraosseous Infusion Needle Set Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Intraosseous Infusion Needle Set Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Intraosseous Infusion Needle Set Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Intraosseous Infusion Needle Set Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Intraosseous Infusion Needle Set Revenue (2020-2025) & (US$ Million)
Figure 80. Intraosseous Infusion Needle Set Industry Chain Mapping
Figure 81. Regional Intraosseous Infusion Needle Set Manufacturing Base Distribution (%)
Figure 82. Global Intraosseous Infusion Needle Set Production Market Share by Region (2020-2031)
Figure 83. Intraosseous Infusion Needle Set Production Process
Figure 84. Regional Intraosseous Infusion Needle Set Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Intraosseous Infusion Needle Set market size from 2025 to 2031?
The annual compound growth rate of the global Intraosseous Infusion Needle Set market is 3.1% 2025 to 2031.
Which region is expected to have the highest market share?
Which companies rank high in the global Intraosseous Infusion Needle Set market?
What was the global market size of Intraosseous Infusion Needle Set in 2025?
What was the global market size of Intraosseous Infusion Needle Set in 2031?
Related Reports
Intraosseous Infusion Needle Set- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Intraosseous Infusion Needle Set was estimated to be worth US$ 70.79 million in 2025 and is projected to reach US$ 87.39 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 119
USD 3950.00
(Single User License)
Global Intraosseous Infusion Needle Set Market Research Report 2026
The global Intraosseous Infusion Needle Set market was valued at US$ 70.79 million in 2025 and is anticipated to reach US$ 87.39 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 106
USD 2900.00
(Single User License)
Global Intraosseous Infusion Needle Set Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Intraosseous Infusion Needle Set market size was US$ 68.9 million in 2024 and is forecast to a readjusted size of US$ 85 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 72
USD 4250.00
(Single User License)
Global Intraosseous Infusion Needle Set Market Research Report 2025
The global market for Intraosseous Infusion Needle Set was valued at US$ 68.9 million in the year 2024 and is projected to reach a revised size of US$ 85 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-01-16
Pages: 71
USD 2900.00
(Single User License)
Intraosseous Infusion Needle Set- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Intraosseous Infusion Needle Set was estimated to be worth US$ 68.9 million in 2024 and is forecast to a readjusted size of US$ 85 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 86
USD 3950.00
(Single User License)
Global Intraosseous Infusion Needle Set Market Insights, Forecast to 2030
Intraosseous Infusion Needle Set is intended for use as an alternative to intravenous access during emergencies, permitting infusion of drugs and fluids.
Published Date: 2024-04-12
Pages: 93
USD 4900.00
(Single User License)
Global Intraosseous Infusion Needle Set Market Research Report 2024
Intraosseous Infusion Needle Set is intended for use as an alternative to intravenous access during emergencies, permitting infusion of drugs and fluids.
Published Date: 2024-01-17
Pages: 84
USD 2900.00
(Single User License)
Intraosseous Infusion Needle Set - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Intraosseous Infusion Needle Set is intended for use as an alternative to intravenous access during emergencies, permitting infusion of drugs and fluids.
Published Date: 2024-01-10
Pages: 101
USD 3950.00
(Single User License)
Intraosseous Infusion Needle Set- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Intraosseous Infusion Needle Set was estimated to be worth US$ 70.79 million in 2025 and is projected to reach US$ 87.39 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 119
USD 3950.00 (Single User License)Global Intraosseous Infusion Needle Set Market Research Report 2026
The global Intraosseous Infusion Needle Set market was valued at US$ 70.79 million in 2025 and is anticipated to reach US$ 87.39 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 106
USD 2900.00 (Single User License)Global Intraosseous Infusion Needle Set Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Intraosseous Infusion Needle Set market size was US$ 68.9 million in 2024 and is forecast to a readjusted size of US$ 85 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 72
USD 4250.00 (Single User License)Global Intraosseous Infusion Needle Set Market Research Report 2025
The global market for Intraosseous Infusion Needle Set was valued at US$ 68.9 million in the year 2024 and is projected to reach a revised size of US$ 85 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-01-16
Pages: 71
USD 2900.00 (Single User License)Intraosseous Infusion Needle Set- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Intraosseous Infusion Needle Set was estimated to be worth US$ 68.9 million in 2024 and is forecast to a readjusted size of US$ 85 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 86
USD 3950.00 (Single User License)Global Intraosseous Infusion Needle Set Market Insights, Forecast to 2030
Intraosseous Infusion Needle Set is intended for use as an alternative to intravenous access during emergencies, permitting infusion of drugs and fluids.
Published: 2024-04-12
Pages: 93
USD 4900.00 (Single User License)Global Intraosseous Infusion Needle Set Market Research Report 2024
Intraosseous Infusion Needle Set is intended for use as an alternative to intravenous access during emergencies, permitting infusion of drugs and fluids.
Published: 2024-01-17
Pages: 84
USD 2900.00 (Single User License)Intraosseous Infusion Needle Set - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Intraosseous Infusion Needle Set is intended for use as an alternative to intravenous access during emergencies, permitting infusion of drugs and fluids.
Published: 2024-01-10
Pages: 101
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now